---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-192381"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2022-07-13T23:59:59+00:00"
generated_at: "2026-06-24T15:41:19.275941+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Sonim completes $12.5M first closing of equity investment from AJP; control changes hands

## Summary
- First closing of $12.5M equity investment by AJP Holding at $0.84/share; AJP now owns ~40.7% of Sonim.
- Second closing for $5M expected ~Aug 1; combined AJP and CEO Peter Liu will own ~52%.
- Board reconstituted: new directors Wang, Steenstra, Cassano; Kneuer and Swenson resigned.
- CFO Robert Tirva resigned; Clay Crolius appointed CFO with base salary $275K.
- Press release: $15.9M in carrier orders; expansion into semi-rugged and 5G markets.

## SEC filing metadata
- accession: 0001193125-22-192381
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2022-07-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 5.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/d305491d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-192381
- JSON: https://secwatch.observer/filing/0001193125-22-192381.json
- Plain text: https://secwatch.observer/filing/0001193125-22-192381.txt

## Key facts
- Executive change
  Robert Tirva resigned as President, Chief Financial Officer and Chief Operating Officer at DNA X, Inc..
  - Action: resigned
  - Role: President, Chief Financial Officer and Chief Operating Officer
  source text: On July 13, 2022, Robert Tirva, President, Chief Financial Officer and Chief Operating Officer (principal financial and accounting officer) of the Company resigned from his positions with the Company and its affiliates.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm
- Executive change
  Clay Crolius was appointed as Chief Financial Officer at DNA X, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: the Board appointed Clay Crolius as Chief Financial Officer (principal financial and accounting officer) of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm
- Executive change
  John Kneuer resigned as Director at DNA X, Inc..
  - Action: resigned
  - Role: Director
  source text: John Kneuer and Sue Swenson resigned from the Board and each respective committee of the Board to which they were appointed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm
- Executive change
  Jeffrey Wang was appointed as Director, Chairman of the Board at DNA X, Inc..
  - Action: appointed
  - Role: Director, Chairman of the Board
  source text: Jeffrey Wang, Director, Chairman of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm
- Executive change
  Sue Swenson resigned as Director at DNA X, Inc..
  - Action: resigned
  - Role: Director
  source text: John Kneuer and Sue Swenson resigned from the Board and each respective committee of the Board to which they were appointed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000119312522192381/0001193125-22-192381-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.